A report of hypothyroidism induced by an over-the-counter fat loss supplement (tiratricol)

International Journal of Sport Nutrition and Exercise Metabolism

Volumn 13, Issue 1, 2003, Pages 112-116

  Scally, Michael C ^a   Hodge, Andrew ^a  

^a Texas Health and Wellness Clinic   (United States)

Author keywords

Supplements; Thyroid; Triax

Indexed keywords

FAT; LIOTHYRONINE; NON PRESCRIPTION DRUG; THYROTROPIN; TIRATRICOL;

ADULT; APPETITE DISORDER; ARTICLE; CASE REPORT; DIET SUPPLEMENTATION; FEMALE; HUMAN; HYPOTHYROIDISM; LETHARGY; LIOTHYRONINE BLOOD LEVEL; MALE; MEDICAL LITERATURE; MUSCLE WEAKNESS; THYROTROPIN BLOOD LEVEL;

EID: 0037352527     PISSN: 10501606     EISSN: None     Source Type: Journal    
DOI: 10.1123/ijsnem.13.1.112     Document Type: Article

References (12)

1. Pittman, C.S., T. Shimizu, A. Burger et al. The noneiodinative pathways of thyroxine metabolism: 3,5,3′,5′-tetraiodthyroacetic acid turnover in normal and fasting human subjects. J. Clin. Endocrinol. Metab. 5:712-716, 1980.
2. Bracco, D., O. Morin, Y. Schutz, H. Liang, E. Jequier, and A.G. Burger. Comparison of the metabolic and endocrine effects of 3,5,3′-triiodothyroacetic acid and thyroxine. J. Clin. Endocrinol. Metab. 77(1):221-228, 1993.
3. Beck-Peccoz, P., A. Sartorio, C. De Medici, G. Grugni, F. Morabito, and G. Faglia. Dissociated thyromimetic effects of 3, 5, 3′-triiodothyroacetic acid (TRIAC) at the pituitary and peripheral tissue levels. J. Endocrinol. Invest. 11(2):113-118, 1988.
4. Radetti, G., L. Persani, G. Molinaro, D. Mannavola, D. Cortelazzi, V.K. Chatterjee, and P. Beck-Peccoz. Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance. Thyroid 7:775-778, 1997.
5. Menegay, C., C. Juge, and A.G. Burger. Pharmacokinetics of 3,5,3′-triiodothyroacetic acid and its effects on serum TSH levels. Acta Endocrinol. (Copenh.) 121:651-658, 1989.
6. Cody, V. Thyroid hormone interactions: molecular conformation, protein binding and hormone action. Endocr. Rev. 61:163, 1980.
7. Lind, P., W. Langsteger, P. Koltringer, and O. Eber. 3, 5, 3′-triiodothyroacetic acid (TRIAC) effects on pituitary thyroid regulation and on peripheral tissue parameters. Nuklearmedizin 28(6):217-220, 1989.
8. Ferner, R.E., A. Burnett, and M.D. Rawlins. Tri-iodothyroacetic acid abuse in a female body builder. Lancet 15(1):383, 1986.
9. Wilson, J.D., D.W. Foster, H.M. Kronenberg, and P.R. Larsen. Williams Textbook of Endocrinology (9th ed.). Philadelphia: WB Saunders, 1998, pp. 404-405.
10. Pittman, J.A., J.O. Tingley, and J.F. Nickerson. Antimetabolic activity of 3,3′5′-triiodo-DL-thyronine in man. Metabolism 9:293-295, 1960.
11. FDA Talk Paper-T00-64, November 21,2000. Available at: 〈http://www.cfsan,fda.gov/~lrd/tptriac.html〉.
12. Kaye, A.D., R.C. Clarke, R. Sabar et al. Herbal medications: current trends in anesthesiology practice- a hospital survey. J. Clin. Anesth. 12:468-471, 2000.